絞り込み

16737

広告

「こころを読む」能力を初めてサルから特定 自閉症治療法確立に貢献 新潟大など (財経新聞)

厚生労働省によると自閉症の症状をもつ人の割合は、約100人に1人いるといわれている。だが自閉症の背後にある脳のメカニズムについて謎が多いという。新潟大学は1日、...

  1. [企業] CAR-Tを開発するGilea...
  2. 「医療機関向け情報(治療ガイドライン、臨...
  3. チタンを用いた生体軟組織用の強力瞬間接着...
  4. [企業] AstraZenecaからRe...

ニュース一覧

「"Rutkowski P "[Author]」の検索結果

352件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Cell-free DNA V600E measurements during BRAF inhibitor therapy of metastatic melanoma: long-term analysis.

Long-term follow-up in adults with extremity osteosarcoma: comparison of different surgical procedures - single-center experience.

Distribution and habitat preferences of the stag beetle Lucanus cervus (L.) in forested areas of Poland.

Signatures of circulating microRNA in four sarcoma subtypes.

Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAF mutation-positive melanoma receiving adjuvant vemurafenib.

Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary Analysis of a Randomized Clinical Trial.

Tomato green waste biochars as sustainable trivalent chromium sorbents.

KEYNOTE-716: Phase III study of adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma.

Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials.

Standard Hot Pressing as a Possible Solution to Obtain Dense KNaNbO Ceramic Doped by ErO and YbO.

Immune checkpoint inhibitors therapy in older patients (≥ 70 years) with metastatic melanoma: a multicentre study.

Quiz. What is your diagnosis?

Treatment Sequencing and Clinical Outcomes in BRAF-Positive and BRAF-Negative Unresectable and Metastatic Melanoma Patients Treated with New Systemic Therapies in Routine Practice.

The Horizontal Raphe of the Human Retina and its Watershed Zones.

Health-related quality of life in patients with fully resected BRAF mutation-positive melanoma receiving adjuvant vemurafenib.

Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study.

Functional outcome of surgical treatment of adults with extremity osteosarcoma after megaprosthetic reconstruction-single-center experience.

Principles of prophylactic and therapeutic management of skin toxicity during treatment with checkpoint inhibitors.

Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatment: A single-arm, open-label, phase II study (CheckMate 172).

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります